Mesoridazine Versus Chlorpromazine in Acute Schizophrenia: A Double-Blind Investigation
Abstract
A double-blind comparison of mesoridazine and chlorpromazine with 91 newly admitted, acutely psychotic patients showed that symptoms grouped in the following composites improved significantly more in the mesoridazine patients than in the chlorpromazine patients: motor activity, attitude and behavior, emotional response, and ideation and thought processes. The mesoridazine patients experienced less sedation than the chlorpromazine patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
